用于生物医学应用的细胞膜衍生纳米材料。
Cell membrane-derived nanomaterials for biomedical applications.
作者信息
Fang Ronnie H, Jiang Yao, Fang Jean C, Zhang Liangfang
机构信息
Department of NanoEngineering and Moores Cancer Center, University of California, San Diego, La Jolla, CA 92093, USA.
Department of NanoEngineering and Moores Cancer Center, University of California, San Diego, La Jolla, CA 92093, USA.
出版信息
Biomaterials. 2017 Jun;128:69-83. doi: 10.1016/j.biomaterials.2017.02.041. Epub 2017 Mar 1.
The continued evolution of biomedical nanotechnology has enabled clinicians to better detect, prevent, manage, and treat human disease. In order to further push the limits of nanoparticle performance and functionality, there has recently been a paradigm shift towards biomimetic design strategies. By taking inspiration from nature, the goal is to create next-generation nanoparticle platforms that can more effectively navigate and interact with the incredibly complex biological systems that exist within the body. Of great interest are cellular membranes, which play essential roles in biointerfacing, self-identification, signal transduction, and compartmentalization. In this review, we explore the major ways in which researchers have directly leveraged cell membrane-derived biomaterials for the fabrication of novel nanotherapeutics and nanodiagnostics. Such emerging technologies have the potential to significantly advance the field of nanomedicine, helping to improve upon traditional modalities while also enabling novel applications.
生物医学纳米技术的持续发展使临床医生能够更好地检测、预防、管理和治疗人类疾病。为了进一步突破纳米颗粒性能和功能的极限,最近出现了向仿生设计策略的范式转变。通过从自然中汲取灵感,目标是创建下一代纳米颗粒平台,使其能够更有效地在体内极其复杂的生物系统中穿梭并与之相互作用。细胞膜备受关注,因为它们在生物界面、自我识别、信号转导和区室化中发挥着重要作用。在这篇综述中,我们探讨了研究人员直接利用细胞膜衍生生物材料制造新型纳米治疗剂和纳米诊断剂的主要方式。此类新兴技术有可能显著推动纳米医学领域的发展,有助于改进传统方法,同时还能实现新的应用。
相似文献
Biomaterials. 2017-6
Adv Sci (Weinh). 2021-4
J Biomed Mater Res A. 2016-1
Bioconjug Chem. 2018-3-20
Adv Mater. 2018-3-27
J Nanobiotechnology. 2021-4-1
Appl Biochem Biotechnol. 2012-1-26
Acta Biomater. 2014-4
Nanomedicine (Lond). 2016-8-2
引用本文的文献
Int J Nanomedicine. 2025-8-13
Bioact Mater. 2025-7-20
Naunyn Schmiedebergs Arch Pharmacol. 2025-7-22
Int J Nanomedicine. 2025-6-30
Asian J Pharm Sci. 2025-6
Int J Nanomedicine. 2025-4-26
本文引用的文献
J Mater Chem B. 2014-12-14
Angew Chem Int Ed Engl. 2001-6-18
Bioeng Transl Med. 2016-5-27
Bioeng Transl Med. 2016-6-3
Trends Biotechnol. 2016-10-27
Adv Colloid Interface Sci. 2016-11-9
Biosens Bioelectron. 2016-12-14
ACS Appl Mater Interfaces. 2016-12-12
Bioconjug Chem. 2017-1-18